Aspen Neuroscience, Inc. (ASPE)

Aspen Neuroscience will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Aspen Neuroscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	-	17.47	17.87
Research & Development	-	41.83	35.59
Operating Expenses	-	59.31	53.46
Operating Income	-66.64	-59.31	-53.46
Interest Expense (Income)	-2.61	-1.79	-4.4
Other Expense (Income)	2.81	4.54	-0.5
Pretax Income	-66.84	-62.06	-48.56
Net Income	-66.84	-62.06	-48.56

Additional Metrics

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-66.51	-62.54	-46.75
Free Cash Flow Growth	-	-	-
EBITDA	-65.31	-59.89	-49.44
Depreciation & Amortization	4.13	3.96	3.51
EBIT	-69.45	-63.85	-52.95